Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis - ScienceDirect
Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data | PLOS ONE
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Pancreatic cancer: a glimmer of hope - Nagendram - 2023 - Trends in Urology & Men's Health - Wiley Online Library
Survival analysis of PDAC patients by Kaplan-Meier plots and log-rank... | Download Scientific Diagram
Pancreatic adenocarcinomas with mature blood vessels have better overall survival | Scientific Reports
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer - Bergquist - 2021 - Cancer Medicine - Wiley Online Library
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma - ScienceDirect
Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Cancers | Free Full-Text | Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
JCM | Free Full-Text | Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study | BMC Cancer | Full Text
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study - Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai, Nai-Jung Chiang, Shih-Chang
Cumulative survival rates of patients with stage IIB pancreatic... | Download Scientific Diagram
![Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/14538/1/fig-2-2x.jpg "Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]")
Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]
Survival and Prognostic Factors in Pancreatic and Ampullary Cancer | Anticancer Research
![PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8faa1d8f68b65770edd2aeca36796df9f4345753/6-Figure2-1.png "PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar")
PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data | Scientific Reports
